(Q34433948)

2 August 2017

1 reference

title

Risk-benefit assessment of methotrexate in the treatment of severe psoriasis (English)

1 reference

2 August 2017

1 reference

Kuijpers AL

1

1 reference

2 August 2017

van de Kerkhof PC

series ordinal

2

1 reference

2 August 2017

publication date

1 January 2000

1 reference

American Journal of Clinical Dermatology

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

27-39

1 reference

https://scigraph.springernature.com/pub.10.2165/00128071-200001010-00003

2 August 2017

exact match

0 references

cites work

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.2165%2F00128071-200001010-00003

Crossref

reference URL

Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00128071-200001010-00003

Crossref

reference URL

10.2165/00128071-200001010-00003

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1017420230

0 references

Fatcat ID

release_62w3srfnmrhtdlkrvdco72swim

1 reference

https://api.fatcat.wiki/v0/release/62w3srfnmrhtdlkrvdco72swim

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference